Advanced Renal Cell Carcinoma: Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 8, p. 511
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2022 AND VI 36 AND IP 8
Results: 6
1
2
Recent Advances in Multiple Myeloma: Applying Real-world Evidence to Clinical Practice.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 8, p. 506
- By:
- Publication type:
- Article
3
Current Treatment of Burkitt Lymphoma and High-Grade B-Cell Lymphomas.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 8, p. 499
- By:
- Publication type:
- Article
4
Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and Therapy.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 8, p. 492
- By:
- Publication type:
- Article
5
Weijing Sun, MD, FACP, Reviews Trends in Gastrointestinal Cancer.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 8, p. 481
- Publication type:
- Article
6
The High Cost of Oral Anticancer Drugs: What Does the Future Hold?
- Published in:
- Oncology (08909091), 2022, v. 36, n. 8, p. 480
- By:
- Publication type:
- Article